1453499-18-7Relevant articles and documents
Design, synthesis and evaluation of MCH receptor 1 antagonists - Part III: Discovery of pre-clinical development candidate BI 186908
Oost, Thorsten,Heckel, Armin,Kley, J?rg T.,Lehmann, Thorsten,Müller, Stephan,Roth, Gerald J.,Rudolf, Klaus,Arndt, Kirsten,Budzinski, Ralph,Lenter, Martin,Lotz, Ralf R.H.,Maier, Gerd-Michael,Markert, Michael,Thomas, Leo,Stenkamp, Dirk
, p. 3275 - 3280 (2015/07/08)
Abstract Although overweight and obesity are highly prevalent conditions, options to treat them are still very limited. As part of our search for safe and effective MCH-R1 antagonists for the treatment of obesity, two series of pyridones and pyridazinones
NEW COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
-
Paragraph 0305, (2013/09/26)
The present invention relates to compounds of general formula I, wherein the groups R1, R2, L1, L2, U and B are as defined in the application, which have valuable pharmacological properties, and in particular modulate the activity of the MCH receptor.
PYRIDINONE AND PYRIDAZINONE DERIVATIVES AS MCH - RECEPTOR MODULATORS
-
Page/Page column 59, (2013/09/26)
The present invention relates to compounds of general formula I, wherein the groups R1, R2, L1, L2, U and B are as defined in the application, which have valuable pharmacological properties, and in particular modulate the activity of the MCH receptor.